Company news
Illumina, Inc. (NASDAQ:ILMN) news
Every Illumina, Inc. press release and news update in one place — announcements, filings coverage, and company updates for investors.
Press releases & updates
Illumina Reports Financial Results for Second Quarter of Fiscal Year 2026
July 30, 2026
Illumina expands Billion Cell Atlas program with new AI drug developers
July 16, 2026
Illumina to Announce Second Quarter 2026 Financial Results on Thursday, July 30, 2026
July 9, 2026
Illumina appoints Michael Sullivan Chief Commercial Officer and Julie Coletti Chief Legal Officer
July 9, 2026
Daniel M. Skovronsky, MD, PhD, appointed to Illumina's Board of Directors
June 23, 2026
Illumina launches StrataMap Spatial Solution, a powerful end-to-end spatial whole transcriptome research solution
June 8, 2026
Illumina and SPT Labtech unveil fireflyGO, enabling faster, simpler targeted oncology research
May 28, 2026
Illumina introduces the first distributed whole-genome sequencing solution for highly sensitive MRD research
May 28, 2026
David P. King elected to Illumina's Board of Directors
May 21, 2026
Illumina releases 2025 Corporate Responsibility Report, expanding access to genomics and accelerating global impact
May 19, 2026
illumine Sets the Benchmark for Secure AI in Childcare with SOC 2 Type II Certification
May 14, 2026
[Latest] Global Targeted DNA RNA Sequencing Market Size/Share Worth USD 46.9 Billion by 2035 at a 18.5% CAGR: Healthcare Foresights (Anal...
May 4, 2026
Illumina Reports Financial Results for First Quarter of Fiscal Year 2026
April 30, 2026
DRAGEN v4.5 supports Illumina's new TruPath Genome and 5-base assays, drives insights across germline, oncology, and multiomic workflows
April 16, 2026
Illumina and the Center for Data-Driven Discovery in Biomedicine bring genomic data and scalable software to the fight against pediatric ...
April 14, 2026
Illumina to Announce First Quarter 2026 Financial Results on Thursday, April 30, 2026
April 9, 2026
Illumina Announces Changes to Board of Directors
April 2, 2026
Illumina and Labcorp expand collaboration to broaden access to precision oncology testing
March 18, 2026
Illumina advances preventive genomics through strategic consortium with Veritas Genetics
March 16, 2026
GRAIL Announces Retirement of CEO Bob Ragusa and Appointment of Josh Ofman, MD, MSHS, as Successor
March 12, 2026
Alliance for Genomic Discovery expands with Regeneron Genetics Center membership and new proteomics data offering
March 5, 2026
Illumina whole-genome sequencing technology to accelerate rare disease testing in Florida
February 27, 2026
Illumina Launches TruPath Genome, Unveils NovaSeq X Roadmap, and Drives Cancer Breakthroughs with Connected Multiomics
February 26, 2026
Illumina partners go beyond the genome, driving cancer breakthroughs using spatial transcriptomics, epigenomics, and proteomics
February 25, 2026
Illumina launches TruPath Genome, setting a new standard in genomic insight
February 24, 2026
Illumina unveils roadmap of groundbreaking NovaSeq X advancements in data quality, output, speed, and flexibility
February 23, 2026
GRAIL Reports Fourth Quarter and Full Year 2025 Financial Results
February 19, 2026
Illumina Reports Financial Results for Fourth Quarter and Fiscal Year 2025
February 5, 2026
Illumina and the San Diego Zoo Wildlife Alliance partner to sequence the Frozen Zoo®, supporting critical conservation genetics efforts g...
February 3, 2026
PacBio Completes Sale of Short-Read Sequencing Assets
February 2, 2026
Illumina completes acquisition of SomaLogic
January 30, 2026
Illumina secures CMS reimbursement for TruSight™ Oncology Comprehensive, expanding access to precision oncology
January 20, 2026
Illumina introduces Billion Cell Atlas to accelerate AI and drug discovery
January 13, 2026
Illumina Announces Preliminary Unaudited Financial Results for Fourth Quarter and Fiscal Year 2025
January 13, 2026
Illumina to Announce Fourth Quarter and Full Year 2025 Financial Results on Thursday, February 5, 2026
January 12, 2026
Alamar Biosciences Announces Close of Oversubscribed Convertible Notes Financing and Expansion of Leadership Team
January 11, 2026
Illumina Appoints Dr. Eric Green as Chief Medical Officer
January 8, 2026
Illumina and PREMIA partner to expand clinical access to CGP in Asia
January 8, 2026
Illumina launches powerful software for connected, intuitive, and scalable multiomic analysis
January 6, 2026
Illumina To Webcast Upcoming Investor Conference
December 16, 2025
/C O R R E C T I O N -- MyOme, Inc/
December 14, 2025
Illumina whole-genome sequencing provides greater insight into genetic signals behind common diseases--according to Nature study
November 12, 2025
Illumina® Protein Prep delivers groundbreaking precision in NGS proteomics for more than 40 customers, ranging from academic institutions...
November 10, 2025
Illumina Responds to Positive Updates from Chinese Ministry of Commerce
November 5, 2025
Standard BioTools Reports Third Quarter 2025 Financial Results
November 4, 2025
Illumina Reports Financial Results for Third Quarter of Fiscal Year 2025
October 30, 2025
Illumina fuels multiomic discovery with launch of 5-base solution, unlocking simultaneous genomic and epigenomic insights
October 15, 2025
Illumina constellation mapped read technology uncovers hard-to-see genomic insights in GeneDx pilot
October 15, 2025
Illumina to Announce Third Quarter 2025 Financial Results on Thursday, October 30, 2025
October 14, 2025
Illumina launches new business to accelerate technology and data-driven discovery
October 1, 2025